General MedicationsINHALATIONStandard
OHTUVAYRE
ENSIFENTRINE
Standard Dose
3MG/2.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OHTUVAYRE is listed in Drugs@FDA under application 217389 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ENSIFENTRINE Form and strength SUSPENSION;INHALATION - 3MG/2.5ML Sponsor VERONA PHARMA Submission history Latest submission status date: 2024-06-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview OHTUVAYRE is listed in Drugs@FDA under application 217389 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ENSIFENTRINE Form and strength SUSPENSION;INHALATION - 3MG/2.5ML Sponsor VERONA PHARMA Submission history Latest submission status date: 2024-06-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.